The Clinical Application of Immunohistochemical Expression of Notch4 Protein in Patients with Colon Adenocarcinoma
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24087502 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marlena Brzozowa-Zasada und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowi…. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.
Abstract (Originalsprache)
The Notch signalling pathway is one of the most conserved and well-characterised pathways involved in cell fate decisions and the development of many diseases, including cancer. Among them, it is worth noting the Notch4 receptor and its clinical application, which may have prognostic value in patients with colon adenocarcinoma. The study was performed on 129 colon adenocarcinomas. Immunohistochemical and fluorescence expression of Notch4 was performed using the Notch4 antibody. The associations between the IHC expression of Notch4 and clinical parameters were analysed using the Chi2 test or Chi2Yatesa test. The Kaplan–Meier analysis and the log-rank test were used to verify the relationship between the intensity of Notch4 expression and the 5-year survival rate of patients. Intracellular localisation of Notch4 was detected by the use of the immunogold labelling method and TEM. 101 (78.29%) samples had strong Notch4 protein expression, and 28 (21.71%) samples were characterised by low expression. The high expression of Notch4 was clearly correlated with the histological grade of the tumour (p < 0.001), PCNA immunohistochemical expression (p < 0.001), depth of invasion (p < 0.001) and angioinvasion (p < 0.001). We can conclude that high expression of Notch4 is correlated with poor prognosis of colon adenocarcinoma patients (log-rank, p < 0.001).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
- Silesian Nanomicroscopy Centre in Zabrze, Silesia LabMed- Research and Implementation Centre, Medical University of Silesia, 40-055 Katowice, Poland.
- Faculty of Health Sciences, Jan Dlugosz University of Czestochowa, 42-200 Czestochowa, Poland.
- Department of Pathology, Pomeranian Medical University, 71-344 Szczecin, Poland.
- Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz 7134845794, Iran.
ORCID-Profile: Marek Michalski, Marek J Łos
Förderung
- Medical University of Silesia
Zitieren
APA
Brzozowa-Zasada, M., Piecuch, A., Michalski, M., Matysiak, N., Kucharzewski, M., & Łos, M. J. (2023). The Clinical Application of Immunohistochemical Expression of Notch4 Protein in Patients with Colon Adenocarcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087502
Vancouver
Brzozowa-Zasada M, Piecuch A, Michalski M, Matysiak N, Kucharzewski M, Łos MJ. The Clinical Application of Immunohistochemical Expression of Notch4 Protein in Patients with Colon Adenocarcinoma. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087502
BibTeX
@article{BrzozowaZasada2023,
author = {Brzozowa-Zasada, Marlena and Piecuch, Adam and Michalski, Marek and Matysiak, Natalia and Kucharzewski, Marek and Łos, Marek J},
title = {The Clinical Application of Immunohistochemical Expression of Notch4 Protein in Patients with Colon Adenocarcinoma},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24087502}
}
EUVIMED